Equitable Holdings heads into the back half of August with an unusual split: the analyst community is lifting targets with unusual conviction, while a small but fast-growing short position is building in the background.
The Street's direction of travel has been decisively bullish. Every analyst action in the past six weeks has been an upward target revision — not a single cut among the recent changes. Wells Fargo raised its target to $64 this week, keeping an Overweight rating, while Keefe Bruyette lifted to $67 last week. Barclays moved to $52 earlier in the month, admittedly the most conservative of the group but still an increase. The consensus mean target runs near $61.50, implying roughly 21% upside from the current $50.84. That gap has been opening, not closing — the stock has gained about 4% over the past month but analysts have been bumping targets faster than the price has moved.
The positioning picture is less straightforward. Short interest has risen 29% over the past week to just over 2.1% of the free float — low in absolute terms, but the pace of accumulation is the notable part. A month ago, SI was running near 4.7 million shares; it crossed 8 million briefly in early July before pulling back sharply around July 10, suggesting some short covering after a crowded phase. The current rebuild — from roughly 4.7 million on August 10 to 6.0 million today — is worth watching even if the absolute level remains modest. Borrow conditions offer no resistance to that build: availability is extraordinarily loose, with roughly 270 million shares available to borrow against a short interest of just 6 million, and the cost to borrow at 0.38% is essentially free. There is no squeeze pressure here.
Options traders have shifted markedly in the opposite direction from the hedging posture that typically accompanies short accumulation. The put/call ratio has dropped to 0.80 — well below its 20-day average of 1.05 and nearly a full standard deviation lighter on puts than usual. As recently as late July, the PCR was running above 1.6. That collapse in put demand suggests call activity has picked up, consistent with the bullish analyst tone. The ORTEX short score holds at 30.5, benign and barely moving over the past two weeks, which confirms that the broader lending and short-momentum signals are not flashing concern.
Equitable's recent earnings track record adds texture. The last two prints each produced single-day gains above 6%, and the five-day drift after both was also positive. The most recent report in late July was the exception — a small dip on the day before recovering nearly 8% over the following week. With the next earnings date pencilled in for September 23, that pattern gives context to why the Street has been comfortable lifting targets: the company has been consistently surprising to the upside.
Insider activity cuts the other way. COO Jeffrey Hurd sold roughly $745,000 worth of stock on August 17 across multiple tranches, adding to a string of director sales over the prior two weeks. The 90-day net insider position is actually positive at around $6.8 million and 143,000 shares, so the recent selling is against a backdrop of longer-term accumulation — but the clustering of sales near the current price level is a signal worth registering alongside the analyst optimism.
What to watch next: whether the short rebuild continues at its recent pace into September, and whether the analyst target upgrades start pulling the stock price closer to the $61–$67 range that most bulls now see as fair value.
See the live data behind this article on ORTEX.
Open EQH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
